Pharma & Healthcare
Global Dapagliflozin Tablets Market Research Report 2026
- Mar 14, 26
- ID: 733191
- Pages: 137
- Figures: 128
- Views: 14
This report delivers a comprehensive overview of the global Dapagliflozin Tablets market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Dapagliflozin Tablets. The Dapagliflozin Tablets market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Dapagliflozin Tablets market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Dapagliflozin Tablets manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Ningbo Minnova Tiankang Pharmaceutical Co., Ltd.
Shandong Lukang Pharmaceutical Co., Ltd.
Jiangsu Hausen Pharmaceutical Group Co., Ltd.
Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd.
Chengdu Beite Pharmaceutical Co., Ltd.
Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd.
Beijing Shuanglu Pharmaceutical Co., Ltd.
AstraZeneca Pharmaceuticals (China) Co., Ltd.
Beijing Fuyuan Pharmaceutical Co., Ltd.
Yiling Wanzhou International Pharmaceutical Co., Ltd.
Rakshit Pharmaceuticals Limited
Zydus Healthcare
Fawn Incorporation
Jabs Biotech
Casca Remedies
Aetos Pharma
Fibovil Pharma
Addii Biotech
Segment by Type
10mg
5mg
by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Dapagliflozin Tablets manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Dapagliflozin Tablets sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The report segments the global Dapagliflozin Tablets market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Dapagliflozin Tablets manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Ningbo Minnova Tiankang Pharmaceutical Co., Ltd.
Shandong Lukang Pharmaceutical Co., Ltd.
Jiangsu Hausen Pharmaceutical Group Co., Ltd.
Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd.
Chengdu Beite Pharmaceutical Co., Ltd.
Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd.
Beijing Shuanglu Pharmaceutical Co., Ltd.
AstraZeneca Pharmaceuticals (China) Co., Ltd.
Beijing Fuyuan Pharmaceutical Co., Ltd.
Yiling Wanzhou International Pharmaceutical Co., Ltd.
Rakshit Pharmaceuticals Limited
Zydus Healthcare
Fawn Incorporation
Jabs Biotech
Casca Remedies
Aetos Pharma
Fibovil Pharma
Addii Biotech
Segment by Type
10mg
5mg
by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Dapagliflozin Tablets manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Dapagliflozin Tablets sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 Dapagliflozin Tablets Market Overview
1.1 Product Definition
1.2 Dapagliflozin Tablets by Type
1.2.1 Global Dapagliflozin Tablets Market Value by Type: 2025 vs 2032
1.2.2 10mg
1.2.3 5mg
1.3 Dapagliflozin Tablets by Application
1.3.1 Global Dapagliflozin Tablets Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Dapagliflozin Tablets Market Size Estimates and Forecasts
1.4.1 Global Dapagliflozin Tablets Revenue 2021–2032
1.4.2 Global Dapagliflozin Tablets Sales 2021–2032
1.4.3 Global Dapagliflozin Tablets Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Dapagliflozin Tablets Market Competition by Manufacturers
2.1 Global Dapagliflozin Tablets Sales Market Share by Manufacturers (2021–2026)
2.2 Global Dapagliflozin Tablets Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Dapagliflozin Tablets Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Dapagliflozin Tablets, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Dapagliflozin Tablets, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Dapagliflozin Tablets, Product Types and Applications
2.7 Global Key Manufacturers of Dapagliflozin Tablets, Date of Entry into the Industry
2.8 Global Dapagliflozin Tablets Market Competitive Situation and Trends
2.8.1 Global Dapagliflozin Tablets Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Dapagliflozin Tablets Players Market Share by Revenue
2.8.3 Global Dapagliflozin Tablets Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Dapagliflozin Tablets Market Scenario by Region
3.1 Global Dapagliflozin Tablets Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Dapagliflozin Tablets Sales by Region: 2021–2032
3.2.1 Global Dapagliflozin Tablets Sales by Region: 2021–2026
3.2.2 Global Dapagliflozin Tablets Sales by Region: 2027–2032
3.3 Global Dapagliflozin Tablets Revenue by Region: 2021–2032
3.3.1 Global Dapagliflozin Tablets Revenue by Region: 2021–2026
3.3.2 Global Dapagliflozin Tablets Revenue by Region: 2027–2032
3.4 North America Dapagliflozin Tablets Market Facts & Figures by Country
3.4.1 North America Dapagliflozin Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Dapagliflozin Tablets Sales by Country (2021–2032)
3.4.3 North America Dapagliflozin Tablets Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Dapagliflozin Tablets Market Facts & Figures by Country
3.5.1 Europe Dapagliflozin Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Dapagliflozin Tablets Sales by Country (2021–2032)
3.5.3 Europe Dapagliflozin Tablets Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dapagliflozin Tablets Market Facts & Figures by Region
3.6.1 Asia Pacific Dapagliflozin Tablets Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Dapagliflozin Tablets Sales by Region (2021–2032)
3.6.3 Asia Pacific Dapagliflozin Tablets Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Dapagliflozin Tablets Market Facts & Figures by Country
3.7.1 Latin America Dapagliflozin Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Dapagliflozin Tablets Sales by Country (2021–2032)
3.7.3 Latin America Dapagliflozin Tablets Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Dapagliflozin Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Dapagliflozin Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Dapagliflozin Tablets Sales by Country (2021–2032)
3.8.3 Middle East and Africa Dapagliflozin Tablets Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Dapagliflozin Tablets Sales by Type (2021–2032)
4.1.1 Global Dapagliflozin Tablets Sales by Type (2021–2026)
4.1.2 Global Dapagliflozin Tablets Sales by Type (2027–2032)
4.1.3 Global Dapagliflozin Tablets Sales Market Share by Type (2021–2032)
4.2 Global Dapagliflozin Tablets Revenue by Type (2021–2032)
4.2.1 Global Dapagliflozin Tablets Revenue by Type (2021–2026)
4.2.2 Global Dapagliflozin Tablets Revenue by Type (2027–2032)
4.2.3 Global Dapagliflozin Tablets Revenue Market Share by Type (2021–2032)
4.3 Global Dapagliflozin Tablets Price by Type (2021–2032)
5 Segment by Application
5.1 Global Dapagliflozin Tablets Sales by Application (2021–2032)
5.1.1 Global Dapagliflozin Tablets Sales by Application (2021–2026)
5.1.2 Global Dapagliflozin Tablets Sales by Application (2027–2032)
5.1.3 Global Dapagliflozin Tablets Sales Market Share by Application (2021–2032)
5.2 Global Dapagliflozin Tablets Revenue by Application (2021–2032)
5.2.1 Global Dapagliflozin Tablets Revenue by Application (2021–2026)
5.2.2 Global Dapagliflozin Tablets Revenue by Application (2027–2032)
5.2.3 Global Dapagliflozin Tablets Revenue Market Share by Application (2021–2032)
5.3 Global Dapagliflozin Tablets Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Ningbo Minnova Tiankang Pharmaceutical Co., Ltd.
6.1.1 Ningbo Minnova Tiankang Pharmaceutical Co., Ltd. Company Information
6.1.2 Ningbo Minnova Tiankang Pharmaceutical Co., Ltd. Description and Business Overview
6.1.3 Ningbo Minnova Tiankang Pharmaceutical Co., Ltd. Dapagliflozin Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Ningbo Minnova Tiankang Pharmaceutical Co., Ltd. Dapagliflozin Tablets Product Portfolio
6.1.5 Ningbo Minnova Tiankang Pharmaceutical Co., Ltd. Recent Developments/Updates
6.2 Shandong Lukang Pharmaceutical Co., Ltd.
6.2.1 Shandong Lukang Pharmaceutical Co., Ltd. Company Information
6.2.2 Shandong Lukang Pharmaceutical Co., Ltd. Description and Business Overview
6.2.3 Shandong Lukang Pharmaceutical Co., Ltd. Dapagliflozin Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Shandong Lukang Pharmaceutical Co., Ltd. Dapagliflozin Tablets Product Portfolio
6.2.5 Shandong Lukang Pharmaceutical Co., Ltd. Recent Developments/Updates
6.3 Jiangsu Hausen Pharmaceutical Group Co., Ltd.
6.3.1 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Company Information
6.3.2 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Description and Business Overview
6.3.3 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Dapagliflozin Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Dapagliflozin Tablets Product Portfolio
6.3.5 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Recent Developments/Updates
6.4 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd.
6.4.1 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Company Information
6.4.2 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Description and Business Overview
6.4.3 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Dapagliflozin Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Dapagliflozin Tablets Product Portfolio
6.4.5 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Recent Developments/Updates
6.5 Chengdu Beite Pharmaceutical Co., Ltd.
6.5.1 Chengdu Beite Pharmaceutical Co., Ltd. Company Information
6.5.2 Chengdu Beite Pharmaceutical Co., Ltd. Description and Business Overview
6.5.3 Chengdu Beite Pharmaceutical Co., Ltd. Dapagliflozin Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Chengdu Beite Pharmaceutical Co., Ltd. Dapagliflozin Tablets Product Portfolio
6.5.5 Chengdu Beite Pharmaceutical Co., Ltd. Recent Developments/Updates
6.6 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd.
6.6.1 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Company Information
6.6.2 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Description and Business Overview
6.6.3 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Dapagliflozin Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Dapagliflozin Tablets Product Portfolio
6.6.5 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Recent Developments/Updates
6.7 Beijing Shuanglu Pharmaceutical Co., Ltd.
6.7.1 Beijing Shuanglu Pharmaceutical Co., Ltd. Company Information
6.7.2 Beijing Shuanglu Pharmaceutical Co., Ltd. Description and Business Overview
6.7.3 Beijing Shuanglu Pharmaceutical Co., Ltd. Dapagliflozin Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Beijing Shuanglu Pharmaceutical Co., Ltd. Dapagliflozin Tablets Product Portfolio
6.7.5 Beijing Shuanglu Pharmaceutical Co., Ltd. Recent Developments/Updates
6.8 AstraZeneca Pharmaceuticals (China) Co., Ltd.
6.8.1 AstraZeneca Pharmaceuticals (China) Co., Ltd. Company Information
6.8.2 AstraZeneca Pharmaceuticals (China) Co., Ltd. Description and Business Overview
6.8.3 AstraZeneca Pharmaceuticals (China) Co., Ltd. Dapagliflozin Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 AstraZeneca Pharmaceuticals (China) Co., Ltd. Dapagliflozin Tablets Product Portfolio
6.8.5 AstraZeneca Pharmaceuticals (China) Co., Ltd. Recent Developments/Updates
6.9 Beijing Fuyuan Pharmaceutical Co., Ltd.
6.9.1 Beijing Fuyuan Pharmaceutical Co., Ltd. Company Information
6.9.2 Beijing Fuyuan Pharmaceutical Co., Ltd. Description and Business Overview
6.9.3 Beijing Fuyuan Pharmaceutical Co., Ltd. Dapagliflozin Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Beijing Fuyuan Pharmaceutical Co., Ltd. Dapagliflozin Tablets Product Portfolio
6.9.5 Beijing Fuyuan Pharmaceutical Co., Ltd. Recent Developments/Updates
6.10 Yiling Wanzhou International Pharmaceutical Co., Ltd.
6.10.1 Yiling Wanzhou International Pharmaceutical Co., Ltd. Company Information
6.10.2 Yiling Wanzhou International Pharmaceutical Co., Ltd. Description and Business Overview
6.10.3 Yiling Wanzhou International Pharmaceutical Co., Ltd. Dapagliflozin Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Yiling Wanzhou International Pharmaceutical Co., Ltd. Dapagliflozin Tablets Product Portfolio
6.10.5 Yiling Wanzhou International Pharmaceutical Co., Ltd. Recent Developments/Updates
6.11 Rakshit Pharmaceuticals Limited
6.11.1 Rakshit Pharmaceuticals Limited Company Information
6.11.2 Rakshit Pharmaceuticals Limited Description and Business Overview
6.11.3 Rakshit Pharmaceuticals Limited Dapagliflozin Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Rakshit Pharmaceuticals Limited Dapagliflozin Tablets Product Portfolio
6.11.5 Rakshit Pharmaceuticals Limited Recent Developments/Updates
6.12 Zydus Healthcare
6.12.1 Zydus Healthcare Company Information
6.12.2 Zydus Healthcare Description and Business Overview
6.12.3 Zydus Healthcare Dapagliflozin Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Zydus Healthcare Dapagliflozin Tablets Product Portfolio
6.12.5 Zydus Healthcare Recent Developments/Updates
6.13 Fawn Incorporation
6.13.1 Fawn Incorporation Company Information
6.13.2 Fawn Incorporation Description and Business Overview
6.13.3 Fawn Incorporation Dapagliflozin Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Fawn Incorporation Dapagliflozin Tablets Product Portfolio
6.13.5 Fawn Incorporation Recent Developments/Updates
6.14 Jabs Biotech
6.14.1 Jabs Biotech Company Information
6.14.2 Jabs Biotech Description and Business Overview
6.14.3 Jabs Biotech Dapagliflozin Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Jabs Biotech Dapagliflozin Tablets Product Portfolio
6.14.5 Jabs Biotech Recent Developments/Updates
6.15 Casca Remedies
6.15.1 Casca Remedies Company Information
6.15.2 Casca Remedies Description and Business Overview
6.15.3 Casca Remedies Dapagliflozin Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Casca Remedies Dapagliflozin Tablets Product Portfolio
6.15.5 Casca Remedies Recent Developments/Updates
6.16 Aetos Pharma
6.16.1 Aetos Pharma Company Information
6.16.2 Aetos Pharma Description and Business Overview
6.16.3 Aetos Pharma Dapagliflozin Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Aetos Pharma Dapagliflozin Tablets Product Portfolio
6.16.5 Aetos Pharma Recent Developments/Updates
6.17 Fibovil Pharma
6.17.1 Fibovil Pharma Company Information
6.17.2 Fibovil Pharma Description and Business Overview
6.17.3 Fibovil Pharma Dapagliflozin Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Fibovil Pharma Dapagliflozin Tablets Product Portfolio
6.17.5 Fibovil Pharma Recent Developments/Updates
6.18 Addii Biotech
6.18.1 Addii Biotech Company Information
6.18.2 Addii Biotech Description and Business Overview
6.18.3 Addii Biotech Dapagliflozin Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Addii Biotech Dapagliflozin Tablets Product Portfolio
6.18.5 Addii Biotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dapagliflozin Tablets Industry Chain Analysis
7.2 Dapagliflozin Tablets Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dapagliflozin Tablets Production Mode & Process Analysis
7.4 Dapagliflozin Tablets Sales and Marketing
7.4.1 Dapagliflozin Tablets Sales Channels
7.4.2 Dapagliflozin Tablets Distributors
7.5 Dapagliflozin Tablets Customer Analysis
8 Dapagliflozin Tablets Market Dynamics
8.1 Dapagliflozin Tablets Industry Trends
8.2 Dapagliflozin Tablets Market Drivers
8.3 Dapagliflozin Tablets Market Challenges
8.4 Dapagliflozin Tablets Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Dapagliflozin Tablets by Type
1.2.1 Global Dapagliflozin Tablets Market Value by Type: 2025 vs 2032
1.2.2 10mg
1.2.3 5mg
1.3 Dapagliflozin Tablets by Application
1.3.1 Global Dapagliflozin Tablets Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Dapagliflozin Tablets Market Size Estimates and Forecasts
1.4.1 Global Dapagliflozin Tablets Revenue 2021–2032
1.4.2 Global Dapagliflozin Tablets Sales 2021–2032
1.4.3 Global Dapagliflozin Tablets Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Dapagliflozin Tablets Market Competition by Manufacturers
2.1 Global Dapagliflozin Tablets Sales Market Share by Manufacturers (2021–2026)
2.2 Global Dapagliflozin Tablets Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Dapagliflozin Tablets Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Dapagliflozin Tablets, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Dapagliflozin Tablets, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Dapagliflozin Tablets, Product Types and Applications
2.7 Global Key Manufacturers of Dapagliflozin Tablets, Date of Entry into the Industry
2.8 Global Dapagliflozin Tablets Market Competitive Situation and Trends
2.8.1 Global Dapagliflozin Tablets Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Dapagliflozin Tablets Players Market Share by Revenue
2.8.3 Global Dapagliflozin Tablets Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Dapagliflozin Tablets Market Scenario by Region
3.1 Global Dapagliflozin Tablets Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Dapagliflozin Tablets Sales by Region: 2021–2032
3.2.1 Global Dapagliflozin Tablets Sales by Region: 2021–2026
3.2.2 Global Dapagliflozin Tablets Sales by Region: 2027–2032
3.3 Global Dapagliflozin Tablets Revenue by Region: 2021–2032
3.3.1 Global Dapagliflozin Tablets Revenue by Region: 2021–2026
3.3.2 Global Dapagliflozin Tablets Revenue by Region: 2027–2032
3.4 North America Dapagliflozin Tablets Market Facts & Figures by Country
3.4.1 North America Dapagliflozin Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Dapagliflozin Tablets Sales by Country (2021–2032)
3.4.3 North America Dapagliflozin Tablets Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Dapagliflozin Tablets Market Facts & Figures by Country
3.5.1 Europe Dapagliflozin Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Dapagliflozin Tablets Sales by Country (2021–2032)
3.5.3 Europe Dapagliflozin Tablets Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dapagliflozin Tablets Market Facts & Figures by Region
3.6.1 Asia Pacific Dapagliflozin Tablets Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Dapagliflozin Tablets Sales by Region (2021–2032)
3.6.3 Asia Pacific Dapagliflozin Tablets Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Dapagliflozin Tablets Market Facts & Figures by Country
3.7.1 Latin America Dapagliflozin Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Dapagliflozin Tablets Sales by Country (2021–2032)
3.7.3 Latin America Dapagliflozin Tablets Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Dapagliflozin Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Dapagliflozin Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Dapagliflozin Tablets Sales by Country (2021–2032)
3.8.3 Middle East and Africa Dapagliflozin Tablets Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Dapagliflozin Tablets Sales by Type (2021–2032)
4.1.1 Global Dapagliflozin Tablets Sales by Type (2021–2026)
4.1.2 Global Dapagliflozin Tablets Sales by Type (2027–2032)
4.1.3 Global Dapagliflozin Tablets Sales Market Share by Type (2021–2032)
4.2 Global Dapagliflozin Tablets Revenue by Type (2021–2032)
4.2.1 Global Dapagliflozin Tablets Revenue by Type (2021–2026)
4.2.2 Global Dapagliflozin Tablets Revenue by Type (2027–2032)
4.2.3 Global Dapagliflozin Tablets Revenue Market Share by Type (2021–2032)
4.3 Global Dapagliflozin Tablets Price by Type (2021–2032)
5 Segment by Application
5.1 Global Dapagliflozin Tablets Sales by Application (2021–2032)
5.1.1 Global Dapagliflozin Tablets Sales by Application (2021–2026)
5.1.2 Global Dapagliflozin Tablets Sales by Application (2027–2032)
5.1.3 Global Dapagliflozin Tablets Sales Market Share by Application (2021–2032)
5.2 Global Dapagliflozin Tablets Revenue by Application (2021–2032)
5.2.1 Global Dapagliflozin Tablets Revenue by Application (2021–2026)
5.2.2 Global Dapagliflozin Tablets Revenue by Application (2027–2032)
5.2.3 Global Dapagliflozin Tablets Revenue Market Share by Application (2021–2032)
5.3 Global Dapagliflozin Tablets Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Ningbo Minnova Tiankang Pharmaceutical Co., Ltd.
6.1.1 Ningbo Minnova Tiankang Pharmaceutical Co., Ltd. Company Information
6.1.2 Ningbo Minnova Tiankang Pharmaceutical Co., Ltd. Description and Business Overview
6.1.3 Ningbo Minnova Tiankang Pharmaceutical Co., Ltd. Dapagliflozin Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Ningbo Minnova Tiankang Pharmaceutical Co., Ltd. Dapagliflozin Tablets Product Portfolio
6.1.5 Ningbo Minnova Tiankang Pharmaceutical Co., Ltd. Recent Developments/Updates
6.2 Shandong Lukang Pharmaceutical Co., Ltd.
6.2.1 Shandong Lukang Pharmaceutical Co., Ltd. Company Information
6.2.2 Shandong Lukang Pharmaceutical Co., Ltd. Description and Business Overview
6.2.3 Shandong Lukang Pharmaceutical Co., Ltd. Dapagliflozin Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Shandong Lukang Pharmaceutical Co., Ltd. Dapagliflozin Tablets Product Portfolio
6.2.5 Shandong Lukang Pharmaceutical Co., Ltd. Recent Developments/Updates
6.3 Jiangsu Hausen Pharmaceutical Group Co., Ltd.
6.3.1 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Company Information
6.3.2 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Description and Business Overview
6.3.3 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Dapagliflozin Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Dapagliflozin Tablets Product Portfolio
6.3.5 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Recent Developments/Updates
6.4 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd.
6.4.1 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Company Information
6.4.2 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Description and Business Overview
6.4.3 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Dapagliflozin Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Dapagliflozin Tablets Product Portfolio
6.4.5 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Recent Developments/Updates
6.5 Chengdu Beite Pharmaceutical Co., Ltd.
6.5.1 Chengdu Beite Pharmaceutical Co., Ltd. Company Information
6.5.2 Chengdu Beite Pharmaceutical Co., Ltd. Description and Business Overview
6.5.3 Chengdu Beite Pharmaceutical Co., Ltd. Dapagliflozin Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Chengdu Beite Pharmaceutical Co., Ltd. Dapagliflozin Tablets Product Portfolio
6.5.5 Chengdu Beite Pharmaceutical Co., Ltd. Recent Developments/Updates
6.6 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd.
6.6.1 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Company Information
6.6.2 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Description and Business Overview
6.6.3 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Dapagliflozin Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Dapagliflozin Tablets Product Portfolio
6.6.5 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Recent Developments/Updates
6.7 Beijing Shuanglu Pharmaceutical Co., Ltd.
6.7.1 Beijing Shuanglu Pharmaceutical Co., Ltd. Company Information
6.7.2 Beijing Shuanglu Pharmaceutical Co., Ltd. Description and Business Overview
6.7.3 Beijing Shuanglu Pharmaceutical Co., Ltd. Dapagliflozin Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Beijing Shuanglu Pharmaceutical Co., Ltd. Dapagliflozin Tablets Product Portfolio
6.7.5 Beijing Shuanglu Pharmaceutical Co., Ltd. Recent Developments/Updates
6.8 AstraZeneca Pharmaceuticals (China) Co., Ltd.
6.8.1 AstraZeneca Pharmaceuticals (China) Co., Ltd. Company Information
6.8.2 AstraZeneca Pharmaceuticals (China) Co., Ltd. Description and Business Overview
6.8.3 AstraZeneca Pharmaceuticals (China) Co., Ltd. Dapagliflozin Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 AstraZeneca Pharmaceuticals (China) Co., Ltd. Dapagliflozin Tablets Product Portfolio
6.8.5 AstraZeneca Pharmaceuticals (China) Co., Ltd. Recent Developments/Updates
6.9 Beijing Fuyuan Pharmaceutical Co., Ltd.
6.9.1 Beijing Fuyuan Pharmaceutical Co., Ltd. Company Information
6.9.2 Beijing Fuyuan Pharmaceutical Co., Ltd. Description and Business Overview
6.9.3 Beijing Fuyuan Pharmaceutical Co., Ltd. Dapagliflozin Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Beijing Fuyuan Pharmaceutical Co., Ltd. Dapagliflozin Tablets Product Portfolio
6.9.5 Beijing Fuyuan Pharmaceutical Co., Ltd. Recent Developments/Updates
6.10 Yiling Wanzhou International Pharmaceutical Co., Ltd.
6.10.1 Yiling Wanzhou International Pharmaceutical Co., Ltd. Company Information
6.10.2 Yiling Wanzhou International Pharmaceutical Co., Ltd. Description and Business Overview
6.10.3 Yiling Wanzhou International Pharmaceutical Co., Ltd. Dapagliflozin Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Yiling Wanzhou International Pharmaceutical Co., Ltd. Dapagliflozin Tablets Product Portfolio
6.10.5 Yiling Wanzhou International Pharmaceutical Co., Ltd. Recent Developments/Updates
6.11 Rakshit Pharmaceuticals Limited
6.11.1 Rakshit Pharmaceuticals Limited Company Information
6.11.2 Rakshit Pharmaceuticals Limited Description and Business Overview
6.11.3 Rakshit Pharmaceuticals Limited Dapagliflozin Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Rakshit Pharmaceuticals Limited Dapagliflozin Tablets Product Portfolio
6.11.5 Rakshit Pharmaceuticals Limited Recent Developments/Updates
6.12 Zydus Healthcare
6.12.1 Zydus Healthcare Company Information
6.12.2 Zydus Healthcare Description and Business Overview
6.12.3 Zydus Healthcare Dapagliflozin Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Zydus Healthcare Dapagliflozin Tablets Product Portfolio
6.12.5 Zydus Healthcare Recent Developments/Updates
6.13 Fawn Incorporation
6.13.1 Fawn Incorporation Company Information
6.13.2 Fawn Incorporation Description and Business Overview
6.13.3 Fawn Incorporation Dapagliflozin Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Fawn Incorporation Dapagliflozin Tablets Product Portfolio
6.13.5 Fawn Incorporation Recent Developments/Updates
6.14 Jabs Biotech
6.14.1 Jabs Biotech Company Information
6.14.2 Jabs Biotech Description and Business Overview
6.14.3 Jabs Biotech Dapagliflozin Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Jabs Biotech Dapagliflozin Tablets Product Portfolio
6.14.5 Jabs Biotech Recent Developments/Updates
6.15 Casca Remedies
6.15.1 Casca Remedies Company Information
6.15.2 Casca Remedies Description and Business Overview
6.15.3 Casca Remedies Dapagliflozin Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Casca Remedies Dapagliflozin Tablets Product Portfolio
6.15.5 Casca Remedies Recent Developments/Updates
6.16 Aetos Pharma
6.16.1 Aetos Pharma Company Information
6.16.2 Aetos Pharma Description and Business Overview
6.16.3 Aetos Pharma Dapagliflozin Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Aetos Pharma Dapagliflozin Tablets Product Portfolio
6.16.5 Aetos Pharma Recent Developments/Updates
6.17 Fibovil Pharma
6.17.1 Fibovil Pharma Company Information
6.17.2 Fibovil Pharma Description and Business Overview
6.17.3 Fibovil Pharma Dapagliflozin Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Fibovil Pharma Dapagliflozin Tablets Product Portfolio
6.17.5 Fibovil Pharma Recent Developments/Updates
6.18 Addii Biotech
6.18.1 Addii Biotech Company Information
6.18.2 Addii Biotech Description and Business Overview
6.18.3 Addii Biotech Dapagliflozin Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Addii Biotech Dapagliflozin Tablets Product Portfolio
6.18.5 Addii Biotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dapagliflozin Tablets Industry Chain Analysis
7.2 Dapagliflozin Tablets Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dapagliflozin Tablets Production Mode & Process Analysis
7.4 Dapagliflozin Tablets Sales and Marketing
7.4.1 Dapagliflozin Tablets Sales Channels
7.4.2 Dapagliflozin Tablets Distributors
7.5 Dapagliflozin Tablets Customer Analysis
8 Dapagliflozin Tablets Market Dynamics
8.1 Dapagliflozin Tablets Industry Trends
8.2 Dapagliflozin Tablets Market Drivers
8.3 Dapagliflozin Tablets Market Challenges
8.4 Dapagliflozin Tablets Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Dapagliflozin Tablets Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Dapagliflozin Tablets Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Dapagliflozin Tablets Market Competitive Situation by Manufacturers in 2025
Table 4. Global Dapagliflozin Tablets Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Dapagliflozin Tablets Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Dapagliflozin Tablets Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Dapagliflozin Tablets Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Dapagliflozin Tablets Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Dapagliflozin Tablets, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Dapagliflozin Tablets, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Dapagliflozin Tablets, Product Types and Applications
Table 12. Global Key Manufacturers of Dapagliflozin Tablets, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Dapagliflozin Tablets Companies by Tier (Tier 1, Tier 2, Tier 3), based on Dapagliflozin Tablets Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Dapagliflozin Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Dapagliflozin Tablets Sales by Region (K Units), 2021–2026
Table 18. Global Dapagliflozin Tablets Sales Market Share by Region (2021–2026)
Table 19. Global Dapagliflozin Tablets Sales by Region (K Units), 2027–2032
Table 20. Global Dapagliflozin Tablets Sales Market Share by Region (2027–2032)
Table 21. Global Dapagliflozin Tablets Revenue by Region (US$ Million), 2021–2026
Table 22. Global Dapagliflozin Tablets Revenue Market Share by Region (2021–2026)
Table 23. Global Dapagliflozin Tablets Revenue by Region (US$ Million), 2027–2032
Table 24. Global Dapagliflozin Tablets Revenue Market Share by Region (2027–2032)
Table 25. North America Dapagliflozin Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Dapagliflozin Tablets Sales by Country (K Units), 2021–2026
Table 27. North America Dapagliflozin Tablets Sales by Country (K Units), 2027–2032
Table 28. North America Dapagliflozin Tablets Revenue by Country (US$ Million), 2021–2026
Table 29. North America Dapagliflozin Tablets Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Dapagliflozin Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Dapagliflozin Tablets Sales by Country (K Units), 2021–2026
Table 32. Europe Dapagliflozin Tablets Sales by Country (K Units), 2027–2032
Table 33. Europe Dapagliflozin Tablets Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Dapagliflozin Tablets Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Dapagliflozin Tablets Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Dapagliflozin Tablets Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Dapagliflozin Tablets Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Dapagliflozin Tablets Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Dapagliflozin Tablets Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Dapagliflozin Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Dapagliflozin Tablets Sales by Country (K Units), 2021–2026
Table 42. Latin America Dapagliflozin Tablets Sales by Country (K Units), 2027–2032
Table 43. Latin America Dapagliflozin Tablets Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Dapagliflozin Tablets Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Dapagliflozin Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Dapagliflozin Tablets Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Dapagliflozin Tablets Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Dapagliflozin Tablets Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Dapagliflozin Tablets Revenue by Country (US$ Million), 2027–2032
Table 50. Global Dapagliflozin Tablets Sales (K Units) by Type (2021–2026)
Table 51. Global Dapagliflozin Tablets Sales (K Units) by Type (2027–2032)
Table 52. Global Dapagliflozin Tablets Sales Market Share by Type (2021–2026)
Table 53. Global Dapagliflozin Tablets Sales Market Share by Type (2027–2032)
Table 54. Global Dapagliflozin Tablets Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Dapagliflozin Tablets Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Dapagliflozin Tablets Revenue Market Share by Type (2021–2026)
Table 57. Global Dapagliflozin Tablets Revenue Market Share by Type (2027–2032)
Table 58. Global Dapagliflozin Tablets Price (US$/Unit) by Type (2021–2026)
Table 59. Global Dapagliflozin Tablets Price (US$/Unit) by Type (2027–2032)
Table 60. Global Dapagliflozin Tablets Sales (K Units) by Application (2021–2026)
Table 61. Global Dapagliflozin Tablets Sales (K Units) by Application (2027–2032)
Table 62. Global Dapagliflozin Tablets Sales Market Share by Application (2021–2026)
Table 63. Global Dapagliflozin Tablets Sales Market Share by Application (2027–2032)
Table 64. Global Dapagliflozin Tablets Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Dapagliflozin Tablets Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Dapagliflozin Tablets Revenue Market Share by Application (2021–2026)
Table 67. Global Dapagliflozin Tablets Revenue Market Share by Application (2027–2032)
Table 68. Global Dapagliflozin Tablets Price (US$/Unit) by Application (2021–2026)
Table 69. Global Dapagliflozin Tablets Price (US$/Unit) by Application (2027–2032)
Table 70. Ningbo Minnova Tiankang Pharmaceutical Co., Ltd. Company Information
Table 71. Ningbo Minnova Tiankang Pharmaceutical Co., Ltd. Description and Business Overview
Table 72. Ningbo Minnova Tiankang Pharmaceutical Co., Ltd. Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Ningbo Minnova Tiankang Pharmaceutical Co., Ltd. Dapagliflozin Tablets Product
Table 74. Ningbo Minnova Tiankang Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 75. Shandong Lukang Pharmaceutical Co., Ltd. Company Information
Table 76. Shandong Lukang Pharmaceutical Co., Ltd. Description and Business Overview
Table 77. Shandong Lukang Pharmaceutical Co., Ltd. Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Shandong Lukang Pharmaceutical Co., Ltd. Dapagliflozin Tablets Product
Table 79. Shandong Lukang Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 80. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Company Information
Table 81. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Description and Business Overview
Table 82. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Dapagliflozin Tablets Product
Table 84. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Recent Developments/Updates
Table 85. Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Company Information
Table 86. Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Description and Business Overview
Table 87. Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Dapagliflozin Tablets Product
Table 89. Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 90. Chengdu Beite Pharmaceutical Co., Ltd. Company Information
Table 91. Chengdu Beite Pharmaceutical Co., Ltd. Description and Business Overview
Table 92. Chengdu Beite Pharmaceutical Co., Ltd. Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Chengdu Beite Pharmaceutical Co., Ltd. Dapagliflozin Tablets Product
Table 94. Chengdu Beite Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 95. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Company Information
Table 96. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Description and Business Overview
Table 97. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Dapagliflozin Tablets Product
Table 99. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 100. Beijing Shuanglu Pharmaceutical Co., Ltd. Company Information
Table 101. Beijing Shuanglu Pharmaceutical Co., Ltd. Description and Business Overview
Table 102. Beijing Shuanglu Pharmaceutical Co., Ltd. Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Beijing Shuanglu Pharmaceutical Co., Ltd. Dapagliflozin Tablets Product
Table 104. Beijing Shuanglu Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 105. AstraZeneca Pharmaceuticals (China) Co., Ltd. Company Information
Table 106. AstraZeneca Pharmaceuticals (China) Co., Ltd. Description and Business Overview
Table 107. AstraZeneca Pharmaceuticals (China) Co., Ltd. Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. AstraZeneca Pharmaceuticals (China) Co., Ltd. Dapagliflozin Tablets Product
Table 109. AstraZeneca Pharmaceuticals (China) Co., Ltd. Recent Developments/Updates
Table 110. Beijing Fuyuan Pharmaceutical Co., Ltd. Company Information
Table 111. Beijing Fuyuan Pharmaceutical Co., Ltd. Description and Business Overview
Table 112. Beijing Fuyuan Pharmaceutical Co., Ltd. Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Beijing Fuyuan Pharmaceutical Co., Ltd. Dapagliflozin Tablets Product
Table 114. Beijing Fuyuan Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 115. Yiling Wanzhou International Pharmaceutical Co., Ltd. Company Information
Table 116. Yiling Wanzhou International Pharmaceutical Co., Ltd. Description and Business Overview
Table 117. Yiling Wanzhou International Pharmaceutical Co., Ltd. Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Yiling Wanzhou International Pharmaceutical Co., Ltd. Dapagliflozin Tablets Product
Table 119. Yiling Wanzhou International Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 120. Rakshit Pharmaceuticals Limited Company Information
Table 121. Rakshit Pharmaceuticals Limited Description and Business Overview
Table 122. Rakshit Pharmaceuticals Limited Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Rakshit Pharmaceuticals Limited Dapagliflozin Tablets Product
Table 124. Rakshit Pharmaceuticals Limited Recent Developments/Updates
Table 125. Zydus Healthcare Company Information
Table 126. Zydus Healthcare Description and Business Overview
Table 127. Zydus Healthcare Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Zydus Healthcare Dapagliflozin Tablets Product
Table 129. Zydus Healthcare Recent Developments/Updates
Table 130. Fawn Incorporation Company Information
Table 131. Fawn Incorporation Description and Business Overview
Table 132. Fawn Incorporation Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Fawn Incorporation Dapagliflozin Tablets Product
Table 134. Fawn Incorporation Recent Developments/Updates
Table 135. Jabs Biotech Company Information
Table 136. Jabs Biotech Description and Business Overview
Table 137. Jabs Biotech Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. Jabs Biotech Dapagliflozin Tablets Product
Table 139. Jabs Biotech Recent Developments/Updates
Table 140. Casca Remedies Company Information
Table 141. Casca Remedies Description and Business Overview
Table 142. Casca Remedies Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. Casca Remedies Dapagliflozin Tablets Product
Table 144. Casca Remedies Recent Developments/Updates
Table 145. Aetos Pharma Company Information
Table 146. Aetos Pharma Description and Business Overview
Table 147. Aetos Pharma Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 148. Aetos Pharma Dapagliflozin Tablets Product
Table 149. Aetos Pharma Recent Developments/Updates
Table 150. Fibovil Pharma Company Information
Table 151. Fibovil Pharma Description and Business Overview
Table 152. Fibovil Pharma Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 153. Fibovil Pharma Dapagliflozin Tablets Product
Table 154. Fibovil Pharma Recent Developments/Updates
Table 155. Addii Biotech Company Information
Table 156. Addii Biotech Description and Business Overview
Table 157. Addii Biotech Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 158. Addii Biotech Dapagliflozin Tablets Product
Table 159. Addii Biotech Recent Developments/Updates
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Dapagliflozin Tablets Distributors List
Table 163. Dapagliflozin Tablets Customers List
Table 164. Dapagliflozin Tablets Market Trends
Table 165. Dapagliflozin Tablets Market Drivers
Table 166. Dapagliflozin Tablets Market Challenges
Table 167. Dapagliflozin Tablets Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
Table 171. Authors List of This Report
List of Figures
Figure 1. Product Picture of Dapagliflozin Tablets
Figure 2. Global Dapagliflozin Tablets Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Dapagliflozin Tablets Market Share by Type: 2025 & 2032
Figure 4. 10mg Product Picture
Figure 5. 5mg Product Picture
Figure 6. Global Dapagliflozin Tablets Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Dapagliflozin Tablets Market Share by Application: 2025 & 2032
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Other
Figure 11. Global Dapagliflozin Tablets Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Dapagliflozin Tablets Market Size (US$ Million), 2021–2032
Figure 13. Global Dapagliflozin Tablets Sales (K Units), 2021–2032
Figure 14. Global Dapagliflozin Tablets Average Price (US$/Unit), 2021–2032
Figure 15. Dapagliflozin Tablets Report Years Considered
Figure 16. Dapagliflozin Tablets Sales Share by Manufacturers in 2025
Figure 17. Global Dapagliflozin Tablets Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Dapagliflozin Tablets Players: Market Share by Revenue in Dapagliflozin Tablets in 2025
Figure 19. Dapagliflozin Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Dapagliflozin Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Dapagliflozin Tablets Sales Market Share by Country (2021–2032)
Figure 22. North America Dapagliflozin Tablets Revenue Market Share by Country (2021–2032)
Figure 23. United States Dapagliflozin Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Dapagliflozin Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Dapagliflozin Tablets Sales Market Share by Country (2021–2032)
Figure 26. Europe Dapagliflozin Tablets Revenue Market Share by Country (2021–2032)
Figure 27. Germany Dapagliflozin Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Dapagliflozin Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Dapagliflozin Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Dapagliflozin Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Dapagliflozin Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Dapagliflozin Tablets Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Dapagliflozin Tablets Revenue Market Share by Region (2021–2032)
Figure 34. China Dapagliflozin Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Dapagliflozin Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Dapagliflozin Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Dapagliflozin Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Dapagliflozin Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Dapagliflozin Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Dapagliflozin Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Dapagliflozin Tablets Sales Market Share by Country (2021–2032)
Figure 42. Latin America Dapagliflozin Tablets Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Dapagliflozin Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Dapagliflozin Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Dapagliflozin Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Dapagliflozin Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Dapagliflozin Tablets Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Dapagliflozin Tablets Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Dapagliflozin Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Dapagliflozin Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Dapagliflozin Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Dapagliflozin Tablets by Type (2021–2032)
Figure 53. Global Revenue Market Share of Dapagliflozin Tablets by Type (2021–2032)
Figure 54. Global Dapagliflozin Tablets Price (US$/Unit) by Type (2021–2032)
Figure 55. Global Sales Market Share of Dapagliflozin Tablets by Application (2021–2032)
Figure 56. Global Revenue Market Share of Dapagliflozin Tablets by Application (2021–2032)
Figure 57. Global Dapagliflozin Tablets Price (US$/Unit) by Application (2021–2032)
Figure 58. Dapagliflozin Tablets Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Dapagliflozin Tablets Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Dapagliflozin Tablets Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Dapagliflozin Tablets Market Competitive Situation by Manufacturers in 2025
Table 4. Global Dapagliflozin Tablets Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Dapagliflozin Tablets Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Dapagliflozin Tablets Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Dapagliflozin Tablets Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Dapagliflozin Tablets Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Dapagliflozin Tablets, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Dapagliflozin Tablets, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Dapagliflozin Tablets, Product Types and Applications
Table 12. Global Key Manufacturers of Dapagliflozin Tablets, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Dapagliflozin Tablets Companies by Tier (Tier 1, Tier 2, Tier 3), based on Dapagliflozin Tablets Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Dapagliflozin Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Dapagliflozin Tablets Sales by Region (K Units), 2021–2026
Table 18. Global Dapagliflozin Tablets Sales Market Share by Region (2021–2026)
Table 19. Global Dapagliflozin Tablets Sales by Region (K Units), 2027–2032
Table 20. Global Dapagliflozin Tablets Sales Market Share by Region (2027–2032)
Table 21. Global Dapagliflozin Tablets Revenue by Region (US$ Million), 2021–2026
Table 22. Global Dapagliflozin Tablets Revenue Market Share by Region (2021–2026)
Table 23. Global Dapagliflozin Tablets Revenue by Region (US$ Million), 2027–2032
Table 24. Global Dapagliflozin Tablets Revenue Market Share by Region (2027–2032)
Table 25. North America Dapagliflozin Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Dapagliflozin Tablets Sales by Country (K Units), 2021–2026
Table 27. North America Dapagliflozin Tablets Sales by Country (K Units), 2027–2032
Table 28. North America Dapagliflozin Tablets Revenue by Country (US$ Million), 2021–2026
Table 29. North America Dapagliflozin Tablets Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Dapagliflozin Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Dapagliflozin Tablets Sales by Country (K Units), 2021–2026
Table 32. Europe Dapagliflozin Tablets Sales by Country (K Units), 2027–2032
Table 33. Europe Dapagliflozin Tablets Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Dapagliflozin Tablets Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Dapagliflozin Tablets Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Dapagliflozin Tablets Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Dapagliflozin Tablets Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Dapagliflozin Tablets Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Dapagliflozin Tablets Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Dapagliflozin Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Dapagliflozin Tablets Sales by Country (K Units), 2021–2026
Table 42. Latin America Dapagliflozin Tablets Sales by Country (K Units), 2027–2032
Table 43. Latin America Dapagliflozin Tablets Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Dapagliflozin Tablets Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Dapagliflozin Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Dapagliflozin Tablets Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Dapagliflozin Tablets Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Dapagliflozin Tablets Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Dapagliflozin Tablets Revenue by Country (US$ Million), 2027–2032
Table 50. Global Dapagliflozin Tablets Sales (K Units) by Type (2021–2026)
Table 51. Global Dapagliflozin Tablets Sales (K Units) by Type (2027–2032)
Table 52. Global Dapagliflozin Tablets Sales Market Share by Type (2021–2026)
Table 53. Global Dapagliflozin Tablets Sales Market Share by Type (2027–2032)
Table 54. Global Dapagliflozin Tablets Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Dapagliflozin Tablets Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Dapagliflozin Tablets Revenue Market Share by Type (2021–2026)
Table 57. Global Dapagliflozin Tablets Revenue Market Share by Type (2027–2032)
Table 58. Global Dapagliflozin Tablets Price (US$/Unit) by Type (2021–2026)
Table 59. Global Dapagliflozin Tablets Price (US$/Unit) by Type (2027–2032)
Table 60. Global Dapagliflozin Tablets Sales (K Units) by Application (2021–2026)
Table 61. Global Dapagliflozin Tablets Sales (K Units) by Application (2027–2032)
Table 62. Global Dapagliflozin Tablets Sales Market Share by Application (2021–2026)
Table 63. Global Dapagliflozin Tablets Sales Market Share by Application (2027–2032)
Table 64. Global Dapagliflozin Tablets Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Dapagliflozin Tablets Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Dapagliflozin Tablets Revenue Market Share by Application (2021–2026)
Table 67. Global Dapagliflozin Tablets Revenue Market Share by Application (2027–2032)
Table 68. Global Dapagliflozin Tablets Price (US$/Unit) by Application (2021–2026)
Table 69. Global Dapagliflozin Tablets Price (US$/Unit) by Application (2027–2032)
Table 70. Ningbo Minnova Tiankang Pharmaceutical Co., Ltd. Company Information
Table 71. Ningbo Minnova Tiankang Pharmaceutical Co., Ltd. Description and Business Overview
Table 72. Ningbo Minnova Tiankang Pharmaceutical Co., Ltd. Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Ningbo Minnova Tiankang Pharmaceutical Co., Ltd. Dapagliflozin Tablets Product
Table 74. Ningbo Minnova Tiankang Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 75. Shandong Lukang Pharmaceutical Co., Ltd. Company Information
Table 76. Shandong Lukang Pharmaceutical Co., Ltd. Description and Business Overview
Table 77. Shandong Lukang Pharmaceutical Co., Ltd. Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Shandong Lukang Pharmaceutical Co., Ltd. Dapagliflozin Tablets Product
Table 79. Shandong Lukang Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 80. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Company Information
Table 81. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Description and Business Overview
Table 82. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Dapagliflozin Tablets Product
Table 84. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Recent Developments/Updates
Table 85. Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Company Information
Table 86. Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Description and Business Overview
Table 87. Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Dapagliflozin Tablets Product
Table 89. Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 90. Chengdu Beite Pharmaceutical Co., Ltd. Company Information
Table 91. Chengdu Beite Pharmaceutical Co., Ltd. Description and Business Overview
Table 92. Chengdu Beite Pharmaceutical Co., Ltd. Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Chengdu Beite Pharmaceutical Co., Ltd. Dapagliflozin Tablets Product
Table 94. Chengdu Beite Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 95. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Company Information
Table 96. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Description and Business Overview
Table 97. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Dapagliflozin Tablets Product
Table 99. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 100. Beijing Shuanglu Pharmaceutical Co., Ltd. Company Information
Table 101. Beijing Shuanglu Pharmaceutical Co., Ltd. Description and Business Overview
Table 102. Beijing Shuanglu Pharmaceutical Co., Ltd. Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Beijing Shuanglu Pharmaceutical Co., Ltd. Dapagliflozin Tablets Product
Table 104. Beijing Shuanglu Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 105. AstraZeneca Pharmaceuticals (China) Co., Ltd. Company Information
Table 106. AstraZeneca Pharmaceuticals (China) Co., Ltd. Description and Business Overview
Table 107. AstraZeneca Pharmaceuticals (China) Co., Ltd. Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. AstraZeneca Pharmaceuticals (China) Co., Ltd. Dapagliflozin Tablets Product
Table 109. AstraZeneca Pharmaceuticals (China) Co., Ltd. Recent Developments/Updates
Table 110. Beijing Fuyuan Pharmaceutical Co., Ltd. Company Information
Table 111. Beijing Fuyuan Pharmaceutical Co., Ltd. Description and Business Overview
Table 112. Beijing Fuyuan Pharmaceutical Co., Ltd. Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Beijing Fuyuan Pharmaceutical Co., Ltd. Dapagliflozin Tablets Product
Table 114. Beijing Fuyuan Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 115. Yiling Wanzhou International Pharmaceutical Co., Ltd. Company Information
Table 116. Yiling Wanzhou International Pharmaceutical Co., Ltd. Description and Business Overview
Table 117. Yiling Wanzhou International Pharmaceutical Co., Ltd. Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Yiling Wanzhou International Pharmaceutical Co., Ltd. Dapagliflozin Tablets Product
Table 119. Yiling Wanzhou International Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 120. Rakshit Pharmaceuticals Limited Company Information
Table 121. Rakshit Pharmaceuticals Limited Description and Business Overview
Table 122. Rakshit Pharmaceuticals Limited Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Rakshit Pharmaceuticals Limited Dapagliflozin Tablets Product
Table 124. Rakshit Pharmaceuticals Limited Recent Developments/Updates
Table 125. Zydus Healthcare Company Information
Table 126. Zydus Healthcare Description and Business Overview
Table 127. Zydus Healthcare Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Zydus Healthcare Dapagliflozin Tablets Product
Table 129. Zydus Healthcare Recent Developments/Updates
Table 130. Fawn Incorporation Company Information
Table 131. Fawn Incorporation Description and Business Overview
Table 132. Fawn Incorporation Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Fawn Incorporation Dapagliflozin Tablets Product
Table 134. Fawn Incorporation Recent Developments/Updates
Table 135. Jabs Biotech Company Information
Table 136. Jabs Biotech Description and Business Overview
Table 137. Jabs Biotech Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. Jabs Biotech Dapagliflozin Tablets Product
Table 139. Jabs Biotech Recent Developments/Updates
Table 140. Casca Remedies Company Information
Table 141. Casca Remedies Description and Business Overview
Table 142. Casca Remedies Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. Casca Remedies Dapagliflozin Tablets Product
Table 144. Casca Remedies Recent Developments/Updates
Table 145. Aetos Pharma Company Information
Table 146. Aetos Pharma Description and Business Overview
Table 147. Aetos Pharma Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 148. Aetos Pharma Dapagliflozin Tablets Product
Table 149. Aetos Pharma Recent Developments/Updates
Table 150. Fibovil Pharma Company Information
Table 151. Fibovil Pharma Description and Business Overview
Table 152. Fibovil Pharma Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 153. Fibovil Pharma Dapagliflozin Tablets Product
Table 154. Fibovil Pharma Recent Developments/Updates
Table 155. Addii Biotech Company Information
Table 156. Addii Biotech Description and Business Overview
Table 157. Addii Biotech Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 158. Addii Biotech Dapagliflozin Tablets Product
Table 159. Addii Biotech Recent Developments/Updates
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Dapagliflozin Tablets Distributors List
Table 163. Dapagliflozin Tablets Customers List
Table 164. Dapagliflozin Tablets Market Trends
Table 165. Dapagliflozin Tablets Market Drivers
Table 166. Dapagliflozin Tablets Market Challenges
Table 167. Dapagliflozin Tablets Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
Table 171. Authors List of This Report
List of Figures
Figure 1. Product Picture of Dapagliflozin Tablets
Figure 2. Global Dapagliflozin Tablets Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Dapagliflozin Tablets Market Share by Type: 2025 & 2032
Figure 4. 10mg Product Picture
Figure 5. 5mg Product Picture
Figure 6. Global Dapagliflozin Tablets Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Dapagliflozin Tablets Market Share by Application: 2025 & 2032
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Other
Figure 11. Global Dapagliflozin Tablets Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Dapagliflozin Tablets Market Size (US$ Million), 2021–2032
Figure 13. Global Dapagliflozin Tablets Sales (K Units), 2021–2032
Figure 14. Global Dapagliflozin Tablets Average Price (US$/Unit), 2021–2032
Figure 15. Dapagliflozin Tablets Report Years Considered
Figure 16. Dapagliflozin Tablets Sales Share by Manufacturers in 2025
Figure 17. Global Dapagliflozin Tablets Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Dapagliflozin Tablets Players: Market Share by Revenue in Dapagliflozin Tablets in 2025
Figure 19. Dapagliflozin Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Dapagliflozin Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Dapagliflozin Tablets Sales Market Share by Country (2021–2032)
Figure 22. North America Dapagliflozin Tablets Revenue Market Share by Country (2021–2032)
Figure 23. United States Dapagliflozin Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Dapagliflozin Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Dapagliflozin Tablets Sales Market Share by Country (2021–2032)
Figure 26. Europe Dapagliflozin Tablets Revenue Market Share by Country (2021–2032)
Figure 27. Germany Dapagliflozin Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Dapagliflozin Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Dapagliflozin Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Dapagliflozin Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Dapagliflozin Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Dapagliflozin Tablets Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Dapagliflozin Tablets Revenue Market Share by Region (2021–2032)
Figure 34. China Dapagliflozin Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Dapagliflozin Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Dapagliflozin Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Dapagliflozin Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Dapagliflozin Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Dapagliflozin Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Dapagliflozin Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Dapagliflozin Tablets Sales Market Share by Country (2021–2032)
Figure 42. Latin America Dapagliflozin Tablets Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Dapagliflozin Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Dapagliflozin Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Dapagliflozin Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Dapagliflozin Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Dapagliflozin Tablets Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Dapagliflozin Tablets Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Dapagliflozin Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Dapagliflozin Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Dapagliflozin Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Dapagliflozin Tablets by Type (2021–2032)
Figure 53. Global Revenue Market Share of Dapagliflozin Tablets by Type (2021–2032)
Figure 54. Global Dapagliflozin Tablets Price (US$/Unit) by Type (2021–2032)
Figure 55. Global Sales Market Share of Dapagliflozin Tablets by Application (2021–2032)
Figure 56. Global Revenue Market Share of Dapagliflozin Tablets by Application (2021–2032)
Figure 57. Global Dapagliflozin Tablets Price (US$/Unit) by Application (2021–2032)
Figure 58. Dapagliflozin Tablets Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Smart Grid Digital Substation Market Research Report 2026
Mar 17, 26
Global Photovoltaic Molded Case Circuit Breaker Market Research Report 2026
Mar 17, 26
Global Roll-Roll Automobile Business Market Research Report 2026
Mar 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232